Schedule 13G ownership disclosure

Aura Biosciences Inc

Common Stock, par value $0.00001 per share · CUSIP: 05153U107

Event date: 2026-02-13

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Advent Life Sciences LLP

    Shares: 2,023,857 · Class: 3.258%

  • Advent Life Sciences Fund I LP

    Shares: 2,023,857 · Class: 3.258%

  • Rajesh Parekh, Ph.D.

    Shares: 2,071,857 · Class: 3.335%

  • Advent Life Sciences Fund III LP

    Shares: 2,023,857 · Class: 3.258%

  • ALS III Carry and Co-Invest LP

    Shares: 2,023,857 · Class: 3.258%

  • Advent-Harrington Impact Fund LP

    Shares: 2,023,857 · Class: 3.258%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001062993-26-001017
Form type
SCHEDULE 13G/A
Filer
Advent Life Sciences LLP
CIK
CIK 1601364
Filed
Feb 17, 2026
Reporting period
Feb 13, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub